ArticleInternational journal of laboratory hematology2026
Analytical and Clinical Performance of the Atellica HEMA 580 Haematology Analyzer: A Comparison With the ADVIA 2120i.
Article in International journal of laboratory hematology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionThe Atellica HEMA 580 is a novel haematology analyser providing eight-part leukocyte differential and optical platelet (PLT) counting. We compared its analytical and clinical performance with that of the ADVIA 2120i.
methodsA total of 796 residual whole blood specimens were analysed. Carryover, linearity and precision were assessed. Inter-instrument comparison was performed for complete blood counts and five-part differential (5-Diff) parameters using Passing-Bablok regression and Bland-Altman analyses. Additional regression against manual microscopy was conducted for flagged samples, including PLT, reticulocytes and common 5-Diff parameters.
resultsCarryover was < 1% for all parameters. Linearity was excellent (R
conclusionThe Atellica HEMA 580 demonstrated reliable analytical performance and strong agreement with the ADVIA 2120i. This supports its suitability as a routine haematology analyser, providing accurate and clinically comparable results.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.